NEU neuren pharmaceuticals limited

NEU is materially undervalued, page-19

  1. 540 Posts.
    lightbulb Created with Sketch. 343
    Fair point but it was still worth a revisit imo to see where we can shave time off next time around.

    For example, the 2 year wait between the EOP2 and trial commencement jumped out at me and the deal with Acadia was done during this period. Obviously, we don’t have these funding issues anymore.

    An an aside, in light of Hottod’s brilliant post yesterday about deal timings, it was interesting to go back and look at all the announcements relating to the negotiations and deals with Acadia relative to Daybue’s progress through the regulatory hurdles and post-approval.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.31
Change
0.770(6.14%)
Mkt cap ! $1.655B
Open High Low Value Volume
$12.96 $14.00 $12.91 $19.76M 1.453M

Buyers (Bids)

No. Vol. Price($)
1 3000 $13.30
 

Sellers (Offers)

Price($) Vol. No.
$13.33 3716 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.